Usana Health Sciences Inc [NYSE: USNA] gained 1.16% or 0.23 points to close at $20.03 with a heavy trading volume of 148861 shares.
It opened the trading session at $19.72, the shares rose to $20.3 and dropped to $19.84, the range by which the price of stock traded the whole day. The daily chart for USNA points out that the company has recorded -33.61% loss over the past six months.
If we look at the average trading volume of 244.44K shares, USNA reached to a volume of 148861 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Usana Health Sciences Inc [USNA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for USNA shares is $39.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on USNA stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Sidoti have made an estimate for Usana Health Sciences Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 23, 2023. While these analysts kept the previous recommendation, Jefferies dropped their target price from $78 to $53. The new note on the price target was released on July 07, 2022, representing the official price target for Usana Health Sciences Inc stock. Previously, the target price had yet another raise to $86, while DA Davidson analysts kept a Neutral rating on USNA stock.
The Price to Book ratio for the last quarter was 0.69, with the Price to Cash per share for the same quarter was set at 7.95. Price to Free Cash Flow for USNA in the course of the last twelve months was 19.59 with Quick ratio for the last quarter at 1.46.
Trading performance analysis for USNA stock
Usana Health Sciences Inc [USNA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 7.06. With this latest performance, USNA shares dropped by -1.48% in over the last four-week period, additionally sinking by -33.61% over the last 6 months – not to mention a drop of -44.19% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for USNA stock in for the last two-week period is set at 46.37, with the RSI for the last a single of trading hit 0.67, and the three-weeks RSI is set at 0.78 for Usana Health Sciences Inc [USNA]. The present Moving Average for the last 50 days of trading for this stock 22.56, while it was recorded at 19.54 for the last single week of trading, and 27.95 for the last 200 days.
Usana Health Sciences Inc [USNA]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Usana Health Sciences Inc [USNA] shares currently have an operating margin of 4.58% and a Gross Margin at 76.11%. Usana Health Sciences Inc’s Net Margin is presently recorded at 1.86%.
Usana Health Sciences Inc (USNA) Capital Structure & Debt Analysis
According to recent financial data for Usana Health Sciences Inc. ( USNA), the Return on Equity (ROE) stands at 3.20%, suggesting modest shareholder returns. The Return on Assets (ROA) is 2.43%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Usana Health Sciences Inc’s Return on Invested Capital (ROIC) is 3.22%, showcasing its effectiveness in deploying capital for earnings.
Usana Health Sciences Inc (USNA) Efficiency & Liquidity Metrics
Based on Usana Health Sciences Inc’s (USNA) latest financial statements, the Debt-to-Equity Ratio is 0.00%, indicating its reliance on debt financing relative to shareholder equity.
Usana Health Sciences Inc (USNA) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Usana Health Sciences Inc. (USNA) effectively leverages its workforce, generating an average of $9994.12 per employee. The company’s liquidity position is robust, with a Current Ratio of 2.23% and a Quick Ratio of 1.46%, indicating strong ability to cover short-term liabilities.
Usana Health Sciences Inc [USNA]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Usana Health Sciences Inc posted 0.64/share EPS, while the average EPS was predicted by analysts to be reported at 0.49/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.15. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for USNA. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Usana Health Sciences Inc go to 2.14%.
An analysis of Institutional ownership at Usana Health Sciences Inc [USNA]
There are presently around $61.83%, or 108.32%% of USNA stock, in the hands of institutional investors. The top three institutional holders of USNA stocks are: BLACKROCK INC. with ownership of 1.77 million shares, which is approximately 9.2323%. VANGUARD GROUP INC, holding 1.57 million shares of the stock with an approximate value of $$71.25 million in USNA stocks shares; and VANGUARD GROUP INC, currently with $$53.35 million in USNA stock with ownership which is approximately 6.1498%.
